S۱۰۰A۹ aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK۱/۲ MAPK and NF-κB pathways

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 197

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-21-2_012

تاریخ نمایه سازی: 27 مهر 1400

چکیده مقاله:

Objective(s): This study aims to investigate the pathogenicity and possible mechanisms of S۱۰۰A۹ function in mice models of scleroderma. Materials and Methods: The content of S۱۰۰A۹ in the skin tissues of mice with scleroderma was determined. Different concentrations of bleomycin (BLM) and S۱۰۰A۹ were subcutaneously injected into the backs of mice simultaneously, and then pathological changes in the skin of these mice were monitored. Specifically, the levels of inflammatory cytokines and alpha smooth muscle actin (α-SMA), the activation of extracellular regulated kinase ۱/۲ (ERK۱/۲), mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) pathways, and the expression of the receptor for advanced glycation end-product (RAGE) in the skin were determined. Results: The content of S۱۰۰A۹ in the skin tissues of mice with scleroderma was determined. Different concentrations of BLM and S۱۰۰A۹ were subcutaneously injected into the backs of mice simultaneously, and then pathological changes in the skin of these mice were monitored. Specifically, the levels of inflammatory cytokines and alpha smooth muscle actin (α-SMA), the activation of extracellular regulated kinase ۱/۲ (ERK۱/۲) mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) pathways, and the expression of the receptor for advanced glycation end-product (RAGE) in the skin were determined. Conclusion: S۱۰۰A۹ aggravates dermal fibrosis in BLM-induced scleroderma (BIS ) mice, and its mechanisms might be mediated by RAGE, ERK۱/۲, and NF-κB pathway.

کلیدواژه ها:

نویسندگان

Xue Xu

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

Zhiyong Chen

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

Xiaoxia Zhu

Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai ۲۰۰۰۴۰, China

Dandan Wang

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

Jun Liang

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

Cheng Zhao

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

Xuebing Feng

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

Jiucun Wang

State Key Laboratory of Genetic Engineering and Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai ۲۰۰۴۳۳, China

Hejian Zou

Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai ۲۰۰۰۴۰, China

Lingyun Sun

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing ۲۱۰۰۰۸, Jiangsu, China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic ...
  • ۲.Yanaba K. Strategy for treatment of fibrosis in systemic sclerosis: ...
  • ۳.Foell D, Wittkowski H, Vogl T, Roth J. S۱۰۰ proteins ...
  • ۴.Ryckman C, Gilbert C, de Médicis R, Lussier A, Vandal ...
  • ۵.Simard JC, Girard D, Tessier PA. Induction of neutrophil degranulation ...
  • ۶.Schnekenburger J, Schick V, Krüger B, Manitz MP, Sorg C, ...
  • ۷.Kurzinski K, Torok KS. Cytokine profiles in localized scleroderma and ...
  • ۸.Tan FK, Zhou X, Mayes MD, Gourh P, Guo X, ...
  • ۹.Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, ...
  • ۱۰.Fietta A, Bardoni A, Salvini R, Passadore I, Morosini M, ...
  • ۱۱.van Bon L, Cossu M, Loof A, Gohar F, Wittkowski ...
  • ۱۲.Xu X, Wu WY, Tu WZ, Chu HY, Zhu XX, ...
  • ۱۳.Yamamoto T, Nishioka K. Cellular and molecular mechanisms of bleomycin-induced ...
  • ۱۴.Foell D, Roth J. Proinflammatory S۱۰۰ proteins in arthritis and ...
  • ۱۵.Kumar RK, Harrison CA, Cornish CJ, Kocher M, Geczy CL. ...
  • ۱۶.Kerkhoff C, Klempt M, Sorg C. Novel insights into structure ...
  • ۱۷.Yamamoto T, Kuroda M, Nishioka K. Animal model of sclerotic ...
  • ۱۸.Nikitorowicz-Buniak J, Shiwen X, Denton CP, Abraham D, Stratton R. ...
  • ۱۹.Xu X, Chen H, Zhu X, Ma Y, Liu Q, ...
  • ۲۰.Fullard N, O'Reilly S. Role of innate immune system in ...
  • ۲۱.Wu M, Mohan C. B-cells in systemic sclerosis: emerging evidence ...
  • ۲۲.Murdaca G, Spanò F, Contatore M, Guastalla A, Puppo F. ...
  • ۲۳.Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, ...
  • ۲۴.Heizmann CW, Ackermann GE, Galichet A. Pathologies involving the S۱۰۰ ...
  • ۲۵.Leclerc E, Vetter SW. The role of S۱۰۰ proteins and ...
  • ۲۶.He M, Kubo H, Ishizawa K, Hegab AE, Yamamoto Y, ...
  • ۲۷.Queisser MA, Kouri FM, Königshoff M, Wygrecka M, Schubert U, ...
  • ۲۸.Yan L, Mathew L, Chellan B, Gardner B, Earley J, ...
  • نمایش کامل مراجع